Is BARD1 p.Pro497= (c.1491A>G) pathogenic?

BARD1 p.Pro497= (c.1491A>G) is classified Benign/Likely benign in BARD1 (ClinVar, Multiple submitters, 11 submitters; last evaluated 2026-01-27). Ultra-rare (popmax 0.0866%, afr); Associated with hereditary neoplastic syndrome.

What condition is associated with BARD1 p.Pro497= (c.1491A>G)?

BARD1 p.Pro497= (c.1491A>G) is associated with hereditary neoplastic syndrome, hereditary breast carcinoma (ClinVar).

How common is BARD1 p.Pro497= (c.1491A>G) in the general population?

BARD1 p.Pro497= (c.1491A>G) is ultra-rare (popmax 0.0866%, afr) (gnomAD).

BARD1 p.Pro497=

c.1491A>G · rs61754117 · VCV184616

Benign/Likely benign Multiple submitters

Classification

Benign/Likely benign

ClinVar

Review

Multiple submitters ★★☆☆

ClinVar · 11 submitters

gnomAD v4.1

Rare

ultra-rare (popmax 0.0866%, afr)

Conditions

hereditary neoplastic syndrome

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI	—	not assessed · no allele here is in the release
Constraint at this position
Conservation	phyloP -5.8	GERP -4.5
Overall
CADD	0.677	PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes

Grpmax group 0.0866% African / African-American · 65/75,042 alleles

Filtering AF 0.0697% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.0636%

Overall 0.00527% 85/1,614,070 alleles · ultra-rare

Ancestry group	Frequency	1 in
African / African-Americangrpmax	0.0866%	1,154
South Asian	0.0132%	7,590
Admixed American	0.01%	10,001
Remaining individualsnot grpmax-eligible	0.0032%	31,252

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene: BARD1
Protein: p.Pro497=
Coding: c.1491A>G
MANE Select: NM_000465
dbSNP: rs61754117
Type: single nucleotide variant
Location: chr2:214767559 (GRCh38)
Gene constraint: LOEUF 1.087 · pLI <0.01 · ClinGen HI 3/3 (gnomAD)
Structure: AlphaFold pLDDT 64.82 · 11 PDB
Residue 497: an α-helix

Full BARD1 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

hereditary neoplastic syndrome — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

Also linked: hereditary breast carcinoma

Similar variants

BARD1 p.Pro497Ser Uncertain significance ★★ ⚠ same residue
BARD1 p.Pro497Thr Uncertain significance ★★ ⚠ same residue
BARD1 p.Pro497Arg Uncertain significance ★ ⚠ same residue
BARD1 p.Pro497fs Pathogenic ★ same residue
BARD1 p.Pro497del Uncertain significance ★ same residue
BARD1 p.Pro497Leu Uncertain significance ★ ⚠ same residue
BARD1 c.1314+1G>A Pathogenic/Likely pathogenic ★★ same condition
BARD1 c.1314+1G>T Likely pathogenic ★★ same condition

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/bard1-p-pro497 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown